Dr. Miglarese is Senior Vice President, Drug Discovery at Caris Life Sciences. Previously, he held the position of SVP, Clinical Laboratories at Caris Life Sciences, responsible for the tissue and liquid biopsy Clinical Labs, Global Regulatory Affairs and Translational Sciences. Prior to that he held titles of SVP Research, Development and Scientific Operations and he initially joined Caris as VP R&D.
Prior to joining Caris, Dr. Miglarese founded OncoNex Consulting LLC and served as an advisor and interim Chief Scientific Officer for Cielo Therapeutics. Before that, he held various positions in the BioPharma and Dx sectors including Chief Scientific Officer at GeneCentric, Vice President of Oncology Translational and Clinical Science at OSI/Astellas, Head of Translational Research at Array BioPharma and Section Head in the Department of Cancer Research at Bayer.
Dr. Miglarese received his BS in Biology from Virginia Tech and earned his PhD from the Department of Microbiology and Immunology at the University of Virginia. He continued his post-doctoral training at Pfizer Central Research and in the Department of Dermatology at Yale University School of Medicine.